Position in AZN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$842,292
-$67,878 QoQ
Shares Held
4,442
-3.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#709
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bridgewater Advisors Inc. holds $24,557,436 across 14 Drug Manufacturers - General names. AZN ranks #8 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
22,989 | $5,838,516 | |
| 2 | LLY |
ELI LILLY & Co
|
3,983 | $4,777,330 | |
| 3 | MRK |
Merck & Co., Inc.
|
23,905 | $3,071,792 | |
| 4 | ABBV |
AbbVie Inc.
|
9,702 | $2,441,411 | |
| 5 | AMGN |
Amgen Inc
|
5,459 | $1,976,813 | |
| 6 | NVS |
Novartis AG
|
10,369 | $1,625,029 | |
| 7 | PFE |
Pfizer Inc
|
62,287 | $1,499,870 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
4,442 | $842,292 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $842,292 | 4,442 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $910,170 | 4,615 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||